Unraveling the Transcriptional Dynamics of NASH Pathogenesis Affecting Atherosclerosis
The prevalence of non-alcoholic steatohepatitis (NASH) is rapidly increasing and associated with cardiovascular disease (CVD), the major cause of mortality in NASH patients. Although sharing common risk factors, the mechanisms by which NASH may directly contribute to the development to CVD remain po...
Gespeichert in:
| Veröffentlicht in: | International journal of molecular sciences 2022-07, Vol.23 (15), p.8229 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 15 |
| container_start_page | 8229 |
| container_title | International journal of molecular sciences |
| container_volume | 23 |
| creator | van den Hoek, Anita M Özsezen, Serdar Caspers, Martien P M van Koppen, Arianne Hanemaaijer, Roeland Verschuren, Lars |
| description | The prevalence of non-alcoholic steatohepatitis (NASH) is rapidly increasing and associated with cardiovascular disease (CVD), the major cause of mortality in NASH patients. Although sharing common risk factors, the mechanisms by which NASH may directly contribute to the development to CVD remain poorly understood. The aim of this study is to gain insight into key molecular processes of NASH that drive atherosclerosis development. Thereto, a time-course study was performed in Ldlr-/-.Leiden mice fed a high-fat diet to induce NASH and atherosclerosis. The effects on NASH and atherosclerosis were assessed and transcriptome analysis was performed. Ldlr-/-.Leiden mice developed obesity, hyperlipidemia and insulin resistance, with steatosis and hepatic inflammation preceding atherosclerosis development. Transcriptome analysis revealed a time-dependent increase in pathways related to NASH and fibrosis followed by an increase in pro-atherogenic processes in the aorta. Gene regulatory network analysis identified specific liver regulators related to lipid metabolism (SC5D, LCAT and HMGCR), inflammation (IL1A) and fibrosis (PDGF, COL3A1), linked to a set of aorta target genes related to vascular inflammation (TNFA) and atherosclerosis signaling (CCL2 and FDFT1). The present study reveals pathogenic liver processes that precede atherosclerosis development and identifies hepatic key regulators driving the atherogenic pathways and regulators in the aorta. |
| doi_str_mv | 10.3390/ijms23158229 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9331250</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2700749906</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-a6d72ce9b8f61898cd73315975317e1301ef8996139457de68b56636aefe10813</originalsourceid><addsrcrecordid>eNpdkUtLAzEUhYMoVqs71zLgxoXVPGaSyUYo9VFBVPCxDWl6p02ZSWoyLfTfm2KV6iYJ5Lvn3nsOQicEXzIm8ZWdNZEyUpSUyh10QHJKexhzsbv17qDDGGcYU0YLuY86rCilEFIcoI93F_QSausmWTuF7C1oF02w89Z6p-vsZuV0Y03MfJU99V-H2Ytup34CDqKNWb-qwLTr2n4qDj6aen3aeIT2Kl1HON7cXfR-d_s2GPYen-8fBv3HnskJbXuajwU1IEdlxUkpSzMWLK0iRcGIAMIwgaqUkhMm80KMgZejgnPGNVRAcElYF11_684XowbGBlwbdK3mwTY6rJTXVv39cXaqJn6pZOpDC5wEzjcCwX8uILaqsdFAXWsHfhEV5ZJjgoucJfTsHzrzi5BMSpTAWORSYp6oi2_KJCNigOp3GILVOjC1HVjCT7cX-IV_EmJf9WiRtA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2700749906</pqid></control><display><type>article</type><title>Unraveling the Transcriptional Dynamics of NASH Pathogenesis Affecting Atherosclerosis</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>van den Hoek, Anita M ; Özsezen, Serdar ; Caspers, Martien P M ; van Koppen, Arianne ; Hanemaaijer, Roeland ; Verschuren, Lars</creator><creatorcontrib>van den Hoek, Anita M ; Özsezen, Serdar ; Caspers, Martien P M ; van Koppen, Arianne ; Hanemaaijer, Roeland ; Verschuren, Lars</creatorcontrib><description>The prevalence of non-alcoholic steatohepatitis (NASH) is rapidly increasing and associated with cardiovascular disease (CVD), the major cause of mortality in NASH patients. Although sharing common risk factors, the mechanisms by which NASH may directly contribute to the development to CVD remain poorly understood. The aim of this study is to gain insight into key molecular processes of NASH that drive atherosclerosis development. Thereto, a time-course study was performed in Ldlr-/-.Leiden mice fed a high-fat diet to induce NASH and atherosclerosis. The effects on NASH and atherosclerosis were assessed and transcriptome analysis was performed. Ldlr-/-.Leiden mice developed obesity, hyperlipidemia and insulin resistance, with steatosis and hepatic inflammation preceding atherosclerosis development. Transcriptome analysis revealed a time-dependent increase in pathways related to NASH and fibrosis followed by an increase in pro-atherogenic processes in the aorta. Gene regulatory network analysis identified specific liver regulators related to lipid metabolism (SC5D, LCAT and HMGCR), inflammation (IL1A) and fibrosis (PDGF, COL3A1), linked to a set of aorta target genes related to vascular inflammation (TNFA) and atherosclerosis signaling (CCL2 and FDFT1). The present study reveals pathogenic liver processes that precede atherosclerosis development and identifies hepatic key regulators driving the atherogenic pathways and regulators in the aorta.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms23158229</identifier><identifier>PMID: 35897797</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Animals ; Aorta ; Arteriosclerosis ; Atherosclerosis ; Atherosclerosis - genetics ; Atherosclerosis - pathology ; Cardiovascular diseases ; Coronary vessels ; Diet, High-Fat - adverse effects ; Disease ; Disease Models, Animal ; Fatty liver ; Fibrosis ; Gene expression ; High fat diet ; Hyperlipidemia ; Inflammation ; Inflammation - metabolism ; Insulin ; Insulin resistance ; Interleukin 1 ; Lipid metabolism ; Lipids ; Liver ; Liver - metabolism ; Metabolic syndrome ; Mice ; Mice, Inbred C57BL ; Monocyte chemoattractant protein 1 ; Mortality ; Network analysis ; Non-alcoholic Fatty Liver Disease - complications ; Non-alcoholic Fatty Liver Disease - genetics ; Obesity ; Oxidative stress ; Pathogenesis ; Platelet-derived growth factor ; Risk analysis ; Risk factors ; Steatosis ; Transcriptomes</subject><ispartof>International journal of molecular sciences, 2022-07, Vol.23 (15), p.8229</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-a6d72ce9b8f61898cd73315975317e1301ef8996139457de68b56636aefe10813</citedby><cites>FETCH-LOGICAL-c412t-a6d72ce9b8f61898cd73315975317e1301ef8996139457de68b56636aefe10813</cites><orcidid>0000-0002-7077-8446 ; 0000-0002-0248-4008 ; 0000-0002-7847-9037</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331250/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331250/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35897797$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van den Hoek, Anita M</creatorcontrib><creatorcontrib>Özsezen, Serdar</creatorcontrib><creatorcontrib>Caspers, Martien P M</creatorcontrib><creatorcontrib>van Koppen, Arianne</creatorcontrib><creatorcontrib>Hanemaaijer, Roeland</creatorcontrib><creatorcontrib>Verschuren, Lars</creatorcontrib><title>Unraveling the Transcriptional Dynamics of NASH Pathogenesis Affecting Atherosclerosis</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>The prevalence of non-alcoholic steatohepatitis (NASH) is rapidly increasing and associated with cardiovascular disease (CVD), the major cause of mortality in NASH patients. Although sharing common risk factors, the mechanisms by which NASH may directly contribute to the development to CVD remain poorly understood. The aim of this study is to gain insight into key molecular processes of NASH that drive atherosclerosis development. Thereto, a time-course study was performed in Ldlr-/-.Leiden mice fed a high-fat diet to induce NASH and atherosclerosis. The effects on NASH and atherosclerosis were assessed and transcriptome analysis was performed. Ldlr-/-.Leiden mice developed obesity, hyperlipidemia and insulin resistance, with steatosis and hepatic inflammation preceding atherosclerosis development. Transcriptome analysis revealed a time-dependent increase in pathways related to NASH and fibrosis followed by an increase in pro-atherogenic processes in the aorta. Gene regulatory network analysis identified specific liver regulators related to lipid metabolism (SC5D, LCAT and HMGCR), inflammation (IL1A) and fibrosis (PDGF, COL3A1), linked to a set of aorta target genes related to vascular inflammation (TNFA) and atherosclerosis signaling (CCL2 and FDFT1). The present study reveals pathogenic liver processes that precede atherosclerosis development and identifies hepatic key regulators driving the atherogenic pathways and regulators in the aorta.</description><subject>Animals</subject><subject>Aorta</subject><subject>Arteriosclerosis</subject><subject>Atherosclerosis</subject><subject>Atherosclerosis - genetics</subject><subject>Atherosclerosis - pathology</subject><subject>Cardiovascular diseases</subject><subject>Coronary vessels</subject><subject>Diet, High-Fat - adverse effects</subject><subject>Disease</subject><subject>Disease Models, Animal</subject><subject>Fatty liver</subject><subject>Fibrosis</subject><subject>Gene expression</subject><subject>High fat diet</subject><subject>Hyperlipidemia</subject><subject>Inflammation</subject><subject>Inflammation - metabolism</subject><subject>Insulin</subject><subject>Insulin resistance</subject><subject>Interleukin 1</subject><subject>Lipid metabolism</subject><subject>Lipids</subject><subject>Liver</subject><subject>Liver - metabolism</subject><subject>Metabolic syndrome</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Monocyte chemoattractant protein 1</subject><subject>Mortality</subject><subject>Network analysis</subject><subject>Non-alcoholic Fatty Liver Disease - complications</subject><subject>Non-alcoholic Fatty Liver Disease - genetics</subject><subject>Obesity</subject><subject>Oxidative stress</subject><subject>Pathogenesis</subject><subject>Platelet-derived growth factor</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>Steatosis</subject><subject>Transcriptomes</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkUtLAzEUhYMoVqs71zLgxoXVPGaSyUYo9VFBVPCxDWl6p02ZSWoyLfTfm2KV6iYJ5Lvn3nsOQicEXzIm8ZWdNZEyUpSUyh10QHJKexhzsbv17qDDGGcYU0YLuY86rCilEFIcoI93F_QSausmWTuF7C1oF02w89Z6p-vsZuV0Y03MfJU99V-H2Ytup34CDqKNWb-qwLTr2n4qDj6aen3aeIT2Kl1HON7cXfR-d_s2GPYen-8fBv3HnskJbXuajwU1IEdlxUkpSzMWLK0iRcGIAMIwgaqUkhMm80KMgZejgnPGNVRAcElYF11_684XowbGBlwbdK3mwTY6rJTXVv39cXaqJn6pZOpDC5wEzjcCwX8uILaqsdFAXWsHfhEV5ZJjgoucJfTsHzrzi5BMSpTAWORSYp6oi2_KJCNigOp3GILVOjC1HVjCT7cX-IV_EmJf9WiRtA</recordid><startdate>20220726</startdate><enddate>20220726</enddate><creator>van den Hoek, Anita M</creator><creator>Özsezen, Serdar</creator><creator>Caspers, Martien P M</creator><creator>van Koppen, Arianne</creator><creator>Hanemaaijer, Roeland</creator><creator>Verschuren, Lars</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7077-8446</orcidid><orcidid>https://orcid.org/0000-0002-0248-4008</orcidid><orcidid>https://orcid.org/0000-0002-7847-9037</orcidid></search><sort><creationdate>20220726</creationdate><title>Unraveling the Transcriptional Dynamics of NASH Pathogenesis Affecting Atherosclerosis</title><author>van den Hoek, Anita M ; Özsezen, Serdar ; Caspers, Martien P M ; van Koppen, Arianne ; Hanemaaijer, Roeland ; Verschuren, Lars</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-a6d72ce9b8f61898cd73315975317e1301ef8996139457de68b56636aefe10813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>Aorta</topic><topic>Arteriosclerosis</topic><topic>Atherosclerosis</topic><topic>Atherosclerosis - genetics</topic><topic>Atherosclerosis - pathology</topic><topic>Cardiovascular diseases</topic><topic>Coronary vessels</topic><topic>Diet, High-Fat - adverse effects</topic><topic>Disease</topic><topic>Disease Models, Animal</topic><topic>Fatty liver</topic><topic>Fibrosis</topic><topic>Gene expression</topic><topic>High fat diet</topic><topic>Hyperlipidemia</topic><topic>Inflammation</topic><topic>Inflammation - metabolism</topic><topic>Insulin</topic><topic>Insulin resistance</topic><topic>Interleukin 1</topic><topic>Lipid metabolism</topic><topic>Lipids</topic><topic>Liver</topic><topic>Liver - metabolism</topic><topic>Metabolic syndrome</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Monocyte chemoattractant protein 1</topic><topic>Mortality</topic><topic>Network analysis</topic><topic>Non-alcoholic Fatty Liver Disease - complications</topic><topic>Non-alcoholic Fatty Liver Disease - genetics</topic><topic>Obesity</topic><topic>Oxidative stress</topic><topic>Pathogenesis</topic><topic>Platelet-derived growth factor</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>Steatosis</topic><topic>Transcriptomes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van den Hoek, Anita M</creatorcontrib><creatorcontrib>Özsezen, Serdar</creatorcontrib><creatorcontrib>Caspers, Martien P M</creatorcontrib><creatorcontrib>van Koppen, Arianne</creatorcontrib><creatorcontrib>Hanemaaijer, Roeland</creatorcontrib><creatorcontrib>Verschuren, Lars</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van den Hoek, Anita M</au><au>Özsezen, Serdar</au><au>Caspers, Martien P M</au><au>van Koppen, Arianne</au><au>Hanemaaijer, Roeland</au><au>Verschuren, Lars</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Unraveling the Transcriptional Dynamics of NASH Pathogenesis Affecting Atherosclerosis</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2022-07-26</date><risdate>2022</risdate><volume>23</volume><issue>15</issue><spage>8229</spage><pages>8229-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>The prevalence of non-alcoholic steatohepatitis (NASH) is rapidly increasing and associated with cardiovascular disease (CVD), the major cause of mortality in NASH patients. Although sharing common risk factors, the mechanisms by which NASH may directly contribute to the development to CVD remain poorly understood. The aim of this study is to gain insight into key molecular processes of NASH that drive atherosclerosis development. Thereto, a time-course study was performed in Ldlr-/-.Leiden mice fed a high-fat diet to induce NASH and atherosclerosis. The effects on NASH and atherosclerosis were assessed and transcriptome analysis was performed. Ldlr-/-.Leiden mice developed obesity, hyperlipidemia and insulin resistance, with steatosis and hepatic inflammation preceding atherosclerosis development. Transcriptome analysis revealed a time-dependent increase in pathways related to NASH and fibrosis followed by an increase in pro-atherogenic processes in the aorta. Gene regulatory network analysis identified specific liver regulators related to lipid metabolism (SC5D, LCAT and HMGCR), inflammation (IL1A) and fibrosis (PDGF, COL3A1), linked to a set of aorta target genes related to vascular inflammation (TNFA) and atherosclerosis signaling (CCL2 and FDFT1). The present study reveals pathogenic liver processes that precede atherosclerosis development and identifies hepatic key regulators driving the atherogenic pathways and regulators in the aorta.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35897797</pmid><doi>10.3390/ijms23158229</doi><orcidid>https://orcid.org/0000-0002-7077-8446</orcidid><orcidid>https://orcid.org/0000-0002-0248-4008</orcidid><orcidid>https://orcid.org/0000-0002-7847-9037</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1422-0067 |
| ispartof | International journal of molecular sciences, 2022-07, Vol.23 (15), p.8229 |
| issn | 1422-0067 1661-6596 1422-0067 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9331250 |
| source | MDPI - Multidisciplinary Digital Publishing Institute; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Animals Aorta Arteriosclerosis Atherosclerosis Atherosclerosis - genetics Atherosclerosis - pathology Cardiovascular diseases Coronary vessels Diet, High-Fat - adverse effects Disease Disease Models, Animal Fatty liver Fibrosis Gene expression High fat diet Hyperlipidemia Inflammation Inflammation - metabolism Insulin Insulin resistance Interleukin 1 Lipid metabolism Lipids Liver Liver - metabolism Metabolic syndrome Mice Mice, Inbred C57BL Monocyte chemoattractant protein 1 Mortality Network analysis Non-alcoholic Fatty Liver Disease - complications Non-alcoholic Fatty Liver Disease - genetics Obesity Oxidative stress Pathogenesis Platelet-derived growth factor Risk analysis Risk factors Steatosis Transcriptomes |
| title | Unraveling the Transcriptional Dynamics of NASH Pathogenesis Affecting Atherosclerosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T01%3A58%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Unraveling%20the%20Transcriptional%20Dynamics%20of%20NASH%20Pathogenesis%20Affecting%20Atherosclerosis&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=van%20den%20Hoek,%20Anita%20M&rft.date=2022-07-26&rft.volume=23&rft.issue=15&rft.spage=8229&rft.pages=8229-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms23158229&rft_dat=%3Cproquest_pubme%3E2700749906%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2700749906&rft_id=info:pmid/35897797&rfr_iscdi=true |